Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhejiang Yatai Pharmaceutical Co Ltd
Deferred Income Tax
Zhejiang Yatai Pharmaceutical Co Ltd
Deferred Income Tax Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
|
Deferred Income Tax
¥3.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
20%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Deferred Income Tax
¥72.3m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Deferred Income Tax
¥117m
|
CAGR 3-Years
14%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Deferred Income Tax
¥148.4m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Deferred Income Tax
¥152.1m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
44%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Deferred Income Tax
¥4.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
119%
|
CAGR 10-Years
N/A
|
|
Zhejiang Yatai Pharmaceutical Co Ltd
Glance View
Zhejiang Yatai Pharmaceutical Co., Ltd. engages in the research, manufacture & distribution of drugs. The company is headquartered in Shaoxing, Zhejiang and currently employs 584 full-time employees. The company went IPO on 2010-03-16. The firm's main business consists of the research, development, production and sales of chemical agents, chemical raw materials and diagnostic reagents, as well as the provision of pharmaceutical research and development outsourcing (CRO) services. The Company’s chemical agents are classified as antibiotics and non-antibiotic drugs. Along with its subsidiaries, the Company provides preclinical research services, clinical research services and other advisory services. The firm distributes its products primarily in domestic markets and overseas markets.
See Also
What is Zhejiang Yatai Pharmaceutical Co Ltd's Deferred Income Tax?
Deferred Income Tax
3.8m
CNY
Based on the financial report for Sep 30, 2025, Zhejiang Yatai Pharmaceutical Co Ltd's Deferred Income Tax amounts to 3.8m CNY.
What is Zhejiang Yatai Pharmaceutical Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
20%
Over the last year, the Deferred Income Tax growth was 0%. The average annual Deferred Income Tax growth rates for Zhejiang Yatai Pharmaceutical Co Ltd have been 4% over the past three years , 5% over the past five years , and 20% over the past ten years .
